We show that 4-1BB antibody targeted delivery of a KLF2 siRNA to vaccine activated CD8+ T cells in tumor bearing mice leads to increased intratumoral content of Trm cells (Fig. 3) and enhances vaccine mediated inhibition of tumor growth (Fig. 4). Here, CD8A is linked to neoplasm.